Risk of carcinoma in women with ovarian endometrioma

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 2, 2011, Pages 529-540

  Kobayashi, Hiroshi ^a   Kajihara, Hirotaka ^a   Yamada, Yoshihiko ^a   Tanase, Yasuhito ^a   Kanayama, Seiji ^a   Furukawa, Naoto ^a   Noguchi, Taketoshi ^a   Haruta, Shoji ^a   Yoshida, Shozo ^a   Naruse, Katsuhiko ^a   Sado, Toshiyuki ^a   Oi, Hidekazu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Clear cell carcinoma; Endometriosis; Epithelial ovarian carcinoma; Molecular genetics; Review; Stress signaling

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; IRINOTECAN; IRON; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN P53; WT1 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1; MICROSATELLITE DNA; PTEN PROTEIN, HUMAN;

ADENOFIBROMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER MODEL; CANCER RESISTANCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; DNA METHYLATION; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM TUMOR; EPITHELIAL OVARIAN CARCINOMA; GENE EXPRESSION; GENETIC MODEL; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MALIGNANT TRANSFORMATION; MENSTRUATION; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; NONHUMAN; OVARIAN BLEEDING; OVARIAN ENDOMETRIOMA; OVARY CARCINOMA; OVARY TUMOR; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERITONEAL CAVITY; REVIEW; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; BLEEDING; CARCINOMA; FEMALE; GENETICS; MOLECULAR BIOLOGY; ONCOGENE RAS; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

CARCINOMA; DNA METHYLATION; ENDOMETRIOSIS; FEMALE; GENES, RAS; GENES, WILMS TUMOR; HEMORRHAGE; HEPATOCYTE NUCLEAR FACTOR 1; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MOLECULAR BIOLOGY; OVARIAN NEOPLASMS; OXIDATIVE STRESS; PTEN PHOSPHOHYDROLASE; RECEPTORS, ESTROGEN; RISK FACTORS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 79957828333     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e267     Document Type: Review

References (85)

1. L.A. Brinton, G. Gridley, I. Persson, J. Baron and A. Bergqvist: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 176, 572-579 (1997) (Pubitemid 27147164)
2. R. Varma, T. Rollason, J.K. Gupta and E.R. Maher: Endometriosis and the neoplastic process. Reproduction 127, 293-304 (2004) (Pubitemid 38425689)
3. J.A. Sampson: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 14, 422-469 (1927)
4. R. Meyer: Uber den staude der frage der adenomyosites adenomyoma in allgemeinen und adenomyometritis sarcomatosa. Zentralb Gynekol. 36, 745 (1919)
5. Y. Osuga: Current concepts of the pathogenesis of endometriosis. Reprod Med Biol. 9, 1-7 (2010)
6. M.K. Cho, C.H. Kim and S.T. Oh: Endometriosis in a patient with Rokitansky-Kuster-Hauser syndrome. J Obstet Gynaecol Res. 35, 994-996 (2009)
7. H. Kobayashi, Y. Yamada, S. Kanayama, N. Furukawa, T. Noguchi, S. Haruta, S, Yoshida, M. Sakata, T. Sado and H. Oi: The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol. 25:39-52 (2009)
8. F. Nezhat, M.S. Datta, V. Hanson, T. Pejovic, C. Nezhat and C. Nezhat: The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril. 90, 1559-1570 (2008)
9. J.C. Lousse, A. Van Langendonckt, R. González-Ramos, S. Defrère, E. Renkin, and J Donnez: Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril. 90, 217-220 (2008) (Pubitemid 351885195)
10. H. Honda, F.F. Barrueto, J. Gogusev, D.D. Im and P.J. Morin: Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol. 6: 59 (2008)
11. S. Allhorn, C. Böing, A.A. Koch, R. Kimmig and I. Gashaw: TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod Biol Endocrinol. 6: 40 (2008)
12. K.N. Khan, M. Kitajima K. Hiraki, A. Fujishita, I. Sekine, T. Ishimaru and H. Masuzaki: Toll-like receptors in innate immunity: role of bacterial endotoxin and toll-like receptor 4 in endometrium and endometriosis. Gynecol Obstet Invest. 68, 40-52 (2009)
13. K.S. Midwood, A.M. Piccinini and S. Sacre: Targeting Toll-like Receptors in Autoimmunity. Curr Drug Targets 2009 Dec 1.
14. X. Jiang, A. Hitchcock, E.J. Bryan, R.H. Watson, P. Englefield, E.J. Thomas and I.G. Campbell: Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res. 56, 3534-3539 (1996) (Pubitemid 26251649)
15. P. Viganó, E. Somigliana, I. Chiodo, A. Abbiati and P. Vercellini: Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Update 12, 77-89 (2006) (Pubitemid 43013749)
16. Y. Wu, Z. Basir, A. Kajdacsy-Balla, E. Strawn, V. Macias, K. Montgomery and S.W. Guo: Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay. Fertil Steril. 79, 710-717 (2003) (Pubitemid 36279674)
17. M. Wells: Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int J Gynecol Pathol. 23, 316-320 (2004) (Pubitemid 39299019)
18. N.F. Vlahos, T. Kalampokas and S. Fotiou: Endometriosis and ovarian cancer: A review. Gynecol Endocrinol. 28, 1-7 (2009)
19. I. Cetin, V. Cozzi and P. Antonazzo: Infertility as a cancer risk factor - a review. Placenta 29, 169-177 (2008)
20. R.B. Ness, J.A. Grisso, C. Cottreau, J. Klapper, R. Vergona, J.E. Wheeler, M. Morgan and J.J. Schlesselman: Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11, 111-117 (2000) (Pubitemid 30112009)
21. A.H. Wu, C.L. Pearce, C.C. Tseng, C. Templeman and M.C. Pike. Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 124, 1409-1415 (2009)
22. N.F. Vlahos, K.P. Economopoulos and S. Fotiou: Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. Best Pract Res Clin Obstet Gynaecol. 24, 39-50 (2010)
23. L. Hanna and M. Adams: Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 20, 339-362 (2006) (Pubitemid 43380604)
24. C.M. Nagle, C.M. Olsen, P.M. Webb, S.J. Jordan, D.C. Whiteman and A.C. Green; Australian Cancer Study Group; Australian Ovarian Cancer Study Group: Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 44, 2477-2484 (2008)
25. D.A. Bell: Origins and molecular pathology of ovarian cancer. Mod Pathol. 18, S19-32 (2005) (Pubitemid 40188615)
26. K.R. Cho: Ovarian cancer update: lessons from morphology, molecules, and mice. Arch Pathol Lab Med. 133, 1775-1781 (2009)
27. I.M. Shih and R.J. Kurman: Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 164, 1511-1518 (2004) (Pubitemid 38529752)
28. I.M. Shih and R.J. Kurman: Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res. 11, 7273-7279 (2005) (Pubitemid 41507684)
29. A.A. Ahmed, D. Etemadmoghadam, J. Temple, A.G. Lynch, M. Riad, R. Sharma, C. Stewart, S. Fereday, C. Caldas, A. Defazio, D. Bowtell and J.D. Brenton: Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol. (2010) Feb 3.
30. K.T. Kuo, T.L. Mao, S. Jones, E. Veras, A. Ayhan, T.L. Wang, R. Glas, D. Slamon, V.E. Velculescu, R.J. Kuman and Ie.M. Shih: Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol. 174, 1597-1601 (2009)
31. A. Aris: Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res. 3, 2 (2010)
32. S. Ogawa, T. Kaku, S. Amada, H. Kobayashi, T. Hirakawa, K. Ariyoshi, T. Kamura and H. Nakano: Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol. 77, 298-304 (2000) (Pubitemid 30317153)
33. E. Somigliana, P. Vigano, F. Parazzini, S. Stoppelli, E. Giambattista and P. Vercellini: Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol. 101, 331-341 (2006) (Pubitemid 44262088)
34. A. Melin, P. Sparén and A. Bergqvist: The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 22, 3021-3026 (2007) (Pubitemid 351696799)
35. M.A. Rossing, K.L. Cushing-Haugen, K.G. Wicklund, J.A. Doherty and N.S. Weiss: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control 19, 1357-1364 (2008)
36. H. Kobayashi, K. Sumimoto, N. Moniwa, M. Imai, K. Takakura, T. Kuromaki, E. Morioka, K. Arisawa and T. Terao: Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 17, 37-43 (2007) (Pubitemid 46213967)
37. H. Kobayashi, H. Kajiwara, S. Kanayama, Y. Yamada, N. Furukawa, T. Noguchi, S. Haruta, S. Yoshida, M. Sakata, T. Sado and H. Oi: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep. 22, 233-240 (2009)
38. I. Gütgemann, N.L. Lehman, P.K. Jackson and T.A. Longacre: Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Mod Pathol. 21, 445-454 (2008) (Pubitemid 351441034)
39. A. Sekizawa, S. Amemiya, J. Otsuka, H. Saito, A. Farina, T. Okai and T. Tachikawa: Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes. Med Electron Microsc. 37, 97-100 (2004) (Pubitemid 38980910)
40. D. Finas, M. Huszar, A. Agic, S. Dogan, H. Kiefel, S. Riedle, D. Gast, R. Marcovich, F. Noack, P. Altevogt, M. Fogel and D. Hornung: L1 cell adhesion molecule (L1CAM) as a pathogenetic factor in endometriosis. Hum Reprod. 23, 1053-1062 (2008) (Pubitemid 351757314)
41. H. Bayramoǧlu and E. Düzcan: Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis. Pathol Oncol Res. 7, 33-38 (2001) (Pubitemid 32591665)
42. X. Jiang, S.J. Morland, A. Hitchcock, E.J. Thomas and I.G. Campbell: Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res. 58, 1707-1712 (1998) (Pubitemid 28215097)
43. M. Erzen and J. Kovacic: Relationship between endometriosis and ovarian cancer. Eur J Gynaecol Oncol. 19, 553-555 (1998) (Pubitemid 29008296)
44. G.M. Zanetta, M.J. Webb, H. Li and G.L. Keeney: Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 79, 18-22 (2000)
45. C.B. Tempfer, M. Simoni, B. Destenaves and B.C. Fauser: Functional genetic polymorphisms and female reproductive disorders: part II - endometriosis. Hum Reprod Update 15, 97-118 (2009)
46. J. Otsuka, T. Okuda, A. Sekizawa, S. Amemiya, H. Saito, T. Okai, M. Kushima and T. Tachikawa: K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma. Med Electron Microsc. 37, 188-192 (2004) (Pubitemid 40576037)
47. R. Franco, O. Schoneveld, A.G. Georgakilas and M.I. Panayiotidis: Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 266, 6-11 (2008)
48. I.G. Campbell and E.J. Thomas: Endometriosis: candidate genes. Hum Reprod Update 7, 15-20 (2001) (Pubitemid 32111962)
49. S. Yamamoto, H. Tsuda, K. Suzuki, M. Takano, S. Tamai and O. Matsubara: An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Virchows Arch. 455, 261-270 (2009)
50. T. Shuin, I. Yamasaki, K. Tamura, H. Okuda, M. Furihata and S. Ashida: Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol. 36, 337-343 (2006) (Pubitemid 44043921)
51. K.W. Kinzler, M.C. Nilbert, L.K. Su, B. Vogelstein, T.M. Bryan, D.B. Levy, K.J. Smith, A.C. Preisinger, P. Hedge and D. McKechnie: Identification of FAP locus genes from chromosome 5q21. Science 253, 661-665 (1991) (Pubitemid 21917199)
52. K. Savitsky, A. Bar-Shira, S. Gilad, G. Rotman, Y. Ziv, L. Vanagaite, D.A. Tagle, S. Smith, T. Uziel, S. Sfez, M. Ashkenazi, I. Pecker, M. Frydman, R. Harnik, S.R. Patanjali, A. Simmons, G.A. Clines, A. Sartiel, R.A. Gatti, L. Chessa, O. Sanal, M.F. Lavin, N.G. Jaspers, A.M. Taylor, C.F. Arlett, T. Miki, S.M. Weissman, M. Lovett, F.S. Collins and Y. Shiloh: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753 (1995)
53. M. Martini, M. Ciccarone, G. Garganese, C. Maggiore, A. Evangelista, S. Rahimi, G. Zannoni, G. Vittori and L.M. Larocca: Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Int J Cancer 102, 398-406 (2002) (Pubitemid 35265880)
54. N. Sato, H. Tsunoda, M. Nishida, Y. Morishita, Y. Takimoto, T. Kubo and M. Noguchi: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res. 60, 7052-7056 (2000) (Pubitemid 32059184)
55. T. Akahane, A. Sekizawa, Y. Purwosunu, M. Nagatsuka and T. Okai: The role of p53 mutation in the carcinomas arising from endometriosis. Int J Gynecol Pathol. 26, 345-351 (2007) (Pubitemid 46986074)
56. Y. Wani and K. Notohara: Ovarian clear cell carcinoma arising in a mucinous cystadenoma. Int J Gynecol Pathol. 28, 584-588 (2009)
57. K. Yamaguchi, M. Mandai, T. Oura, N. Matsumura, J. Hamanishi, T. Baba, S. Matsui, S.K. Murphy and I. Konishi: Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene (2010) Jan 11.
58. S. Toyokuni: Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med. 20, 553-566 (1996) (Pubitemid 26097272)
59. J.A. Campbell: Effects of precipitated silica and of iron oxide on the incidence of primary lung tumours in mice. Br Med J. 2, 275-280 (1940)
60. H.G. Richmond: Induction of sarcoma in the rat by iron-dextran complex. Br Med J. 1, 947-949 (1959)
61. S. Okada and O. Midorikawa: Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med. 29, 485-491 (1982) (Pubitemid 13253150)
62. F. Suzuki, J. Akahira, I. Miura, T. Suzuki, K. Ito, S. Hayashi, H. Sasano and N. Yaegashi: Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 99, 2365-2372 (2008)
63. Y. Lu, M.H. Liu, Y. Zheng, S.W. Guo and X.S. Liu: Clinicopathological features of 67 cases of endometriosis-associated epithelial ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi. 44, 832-836 (2009)
64. R. Vang, B.P. Whitaker, A.I. Farhood, E.G. Silva, J.Y. Ro and M.T. Deavers: Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int J Gynecol Pathol. 20, 252-259 (2001) (Pubitemid 32578111)
65. M. Fujimura, T. Hidaka, K. Kataoka, Y. Yamakawa, S. Akada, A. Teranishi and S. Saito: Absence of estrogen receptor-alpha expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinoma. Am J Surg Pathol. 25, 667-672 (2001) (Pubitemid 32423367)
66. M. Mandai, K. Yamaguchi, N. Matsumura, T. Baba and I. Konishi: Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 14, 383-391 (2009)
67. T. Akahane, A. Sekizawa, T. Okuda, M. Kushima, H. Saito and T. Okai: Disappearance of steroid hormone dependency during malignant transformation of ovarian clear cell cancer. Int J Gynecol Pathol. 24, 369-376 (2005) (Pubitemid 41368291)
68. L.P. Nolan and M.K. Heatley: The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary. Int J Gynecol Pathol. 20, 155-159 (2001) (Pubitemid 32239207)
69. G. Acs, T. Pasha and P.J. Zhang: WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol. 23, 110-118 (2004) (Pubitemid 38391769)
70. S. Gupta, K. Joshi, J.D. Wig and S.K: Arora. High frequency of loss of allelic integrity at Wilms' tumor suppressor gene-1 locus in advanced breast tumors associated with aggressiveness of the tumor. Indian J Cancer 46, 303-310 (2009)
71. C.J. Stewart, B.A. Brennan, T. Chan and J. Netreba: WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis. Pathology 40, 592-599 (2008)
72. M. Köbel, S.E. Kalloger, J. Carrick, D. Huntsman, H. Asad, E. Oliva, C.A. Ewanowich, R.A. Soslow and C.B. Gilks: A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol. 33, 14-21 (2009)
73. M. Kaneuchi, M. Sasaki, Y. Tanaka, H. Shiina, H. Yamada, R. Yamamoto, N. Sakuragi, H. Enokida, M. Verma and R Dahiya: WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer 104, 1924-1930 (2005) (Pubitemid 41513176)
74. Y. Wu, E. Strawn, Z. Basir, G. Halverson and S.W. Guo: Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril. 87, 24-32 (2007) (Pubitemid 46013877)
75. F. Nezhat, C. Cohen, J. Rahaman, H. Gretz, P. Cole and T. Kalir: Comparative immunohistochemical studies of bcl- 2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94, 2935-2940 (2002) (Pubitemid 34547693)
76. S. Komiyama, D. Aoki, Y. Katsuki and S. Nozawa: Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis. Eur J Obstet Gynecol Reprod Biol. 127, 130-136 (2006) (Pubitemid 43947435)
77. H. Mizumoto, T. Saito, K. Ashihara, M. Nishimura, M. Takehara, R. Tanaka, E. Ito and R. Kudo: Expression of matrix metalloproteinases in ovarian endometriomas: immunohistochemical study and enzyme immunoassay. Life Sci. 71, 259-273 (2002) (Pubitemid 34597189)
78. A. Kim, T. Enomoto, S. Serada, Y. Ueda, T. Takahashi, B. Ripley, T. Miyatake, M. Fujita, C.M. Lee, K. Morimoto, M. Fujimoto, T. Kimura and T. Naka: Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Int J Cancer 125, 2316-2322 (2009)
79. H. Itamochi, J. Kigawa, H. Sultana, T. Iba, R. Akeshima, S. Kamazawa, Y. Kanamori and N. Terakawa: Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. Jpn J Cancer Res. 93, 723-728 (2002) (Pubitemid 34846281)
80. T. Nakazato, T. Kanuma, T. Tamura, L.S. Faried, H. Aoki and T. Minegishi: Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer. Int J Gynecol Cancer 17, 426-432 (2007) (Pubitemid 46426772)
81. H. Kobayashi, Y. Yamada, S. Kanayama, N. Furukawa, T. Noguchi, S. Haruta, S. Yoshida, M. Sakata, T. Sado and H. Oi: The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer 19, 471-479 (2009)
82. P. Sève and C. Dumontet: Chemoresistance in non-small cell lung cancer. Curr Med Chem Anticancer Agents 5, 73-88 (2005) (Pubitemid 40081296)
83. S. Yamamoto, H. Tsuda, T. Yoshikawa, K. Kudoh, T. Kita, K. Furuya, S. Tamai and O. Matsubara: Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol. 31, 999-1006 (2007) (Pubitemid 47012295)
84. S. Yamamoto, H. Tsuda, K. Miyai, M. Takano, S. Tamai and O. Matsubara: Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. Virchows Arch. 455, 413-422 (2009)
85. S. Yamamoto, H. Tsuda, M. Takano, T. Kita, K. Kudoh, K. Furuya, S. Tamai and O. Matsubara: Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors. Mod Pathol. 21, 115-124 (2008) (Pubitemid 351172160)